Transplantation and Cellular Therapy

Risk and predictive factors for candidemia after allogeneic hematopoietic cell transplantation: JSTCT Transplant Complications Working Group

Transplantation and Cellular Therapy ◽

10.1016/j.jtct.2021.12.020 ◽

2022 ◽

Author(s):

Shun-ichi Kimura ◽

Kazuaki Kameda ◽

Kaito Harada ◽

Masuho Saburi ◽

Keiji Okinaka ◽

...

Keyword(s):

Cell Transplantation ◽

Predictive Factors ◽

Working Group ◽

Hematopoietic Cell Transplantation ◽

Hematopoietic Cell ◽

Allogeneic Hematopoietic Cell Transplantation ◽

Transplant Complications

Download Full-text

PTCy-based Haploidentical vs Matched Unrelated Donor Peripheral Blood HSCT Using Myeloablative Targeted Busulfan-based Conditioning for Pediatric Acute Leukemia

Transplantation and Cellular Therapy ◽

10.1016/j.jtct.2022.01.002 ◽

2022 ◽

Author(s):

Kyung Taek Hong ◽

Hyun Jin Park ◽

Bo Kyung Kim ◽

Hong Yul An ◽

Jung Yoon Choi ◽

...

Keyword(s):

Acute Leukemia ◽

Peripheral Blood ◽

Unrelated Donor ◽

Matched Unrelated Donor

Download Full-text

Early recovery of myeloid-derived suppressor cells after allogeneic hematopoietic cells: comparison of post-transplantation cyclophosphamide to standard graft-versus-host disease prophylaxis

Transplantation and Cellular Therapy ◽

10.1016/j.jtct.2021.12.019 ◽

2022 ◽

Author(s):

Benjamin Oshrine ◽

Patrick Innamarato ◽

Holly Branthoover ◽

Luz Nagle ◽

Patrick Verdugo ◽

...

Keyword(s):

Graft Versus Host Disease ◽

Hematopoietic Cells ◽

Suppressor Cells ◽

Myeloid Derived Suppressor Cells ◽

Post Transplantation ◽

Early Recovery ◽

Host Disease ◽

Graft Versus Host

Download Full-text

Human cytomegalovirus-specific T-cell reconstitution and late-onset cytomegalovirus infection in hematopoietic stem cell transplant recipients following letermovir prophylaxis

Transplantation and Cellular Therapy ◽

10.1016/j.jtct.2022.01.008 ◽

2022 ◽

Author(s):

Elisa Gabanti ◽

Oscar Borsani ◽

Anna Amelia Colombo ◽

Federica Zavaglio ◽

Luana Binaschi ◽

...

Keyword(s):

Stem Cell ◽

Human Cytomegalovirus ◽

Cytomegalovirus Infection ◽

Hematopoietic Stem Cell Transplant ◽

Stem Cell Transplant ◽

Late Onset ◽

Cell Transplant ◽

Transplant Recipients ◽

Hematopoietic Stem ◽

T Cell Reconstitution

Download Full-text

Real-world Experience of Cryopreserved Allogeneic Hematopoietic Grafts in the COVID-19 Pandemic: A Single Center Report

Transplantation and Cellular Therapy ◽

10.1016/j.jtct.2022.01.010 ◽

2022 ◽

Author(s):

Andriyana K. Bankova ◽

Joseph Caveney ◽

Bin Yao ◽

Teresa L. Ramos ◽

Jan Bögeholz ◽

...

Keyword(s):

Real World ◽

Single Center ◽

Center Report

Download Full-text

Outcomes Following Intolerance to Tacrolimus/Sirolimus Graft-Versus-Host Disease Prophylaxis for Allogeneic Hematopoietic Cell Transplantation

Transplantation and Cellular Therapy ◽

10.1016/j.jtct.2022.01.003 ◽

2022 ◽

Author(s):

Abu-Sayeef Mirza ◽

Ankita Tandon ◽

Dakota Jenneman ◽

Shu Cao ◽

Thomas Brimer ◽

...

Keyword(s):

Cell Transplantation ◽

Graft Versus Host Disease ◽

Hematopoietic Cell Transplantation ◽

Hematopoietic Cell ◽

Allogeneic Hematopoietic Cell Transplantation ◽

Host Disease ◽

Graft Versus Host

Download Full-text

Incidence and risk factors of transplant-associated thrombotic microangiopathy (TA-TMA): a systematic review and meta-analysis

Transplantation and Cellular Therapy ◽

10.1016/j.jtct.2022.01.009 ◽

2022 ◽

Author(s):

Victoria Van Benschoten ◽

Cayla Roy ◽

Rohit Gupta ◽

Lara Ouellette ◽

Sangeeta Hingorani ◽

...

Keyword(s):

Risk Factors ◽

Systematic Review ◽

Thrombotic Microangiopathy ◽

Meta Analysis

Download Full-text

Mother donors improve outcomes after HLA haploidentical transplantation: A Study by the Cellular Therapy and Immunobiology Working Party of the EBMT

Transplantation and Cellular Therapy ◽

10.1016/j.jtct.2022.01.001 ◽

2022 ◽

Author(s):

Loredana Ruggeri ◽

Dirk-Jan Eikema ◽

Attilio Bondanza ◽

Maddalena Noviello ◽

Anja van Biezen ◽

...

Keyword(s):

Cellular Therapy ◽

Working Party ◽

Haploidentical Transplantation

Download Full-text

Mature naive B cells regulate the outcome of murine acute graft-versus-host disease in an IL-10 independent manner

Transplantation and Cellular Therapy ◽

10.1016/j.jtct.2022.01.004 ◽

2022 ◽

Author(s):

Rômulo Gonçalves Galvani ◽

Suelen Martins Perobelli ◽

Triciana Gonçalves-Silva ◽

Pedro Henrique Oliveira Vianna ◽

Cecília B. Cavazzoni ◽

...

Keyword(s):

B Cells ◽

Graft Versus Host Disease ◽

Independent Manner ◽

Host Disease ◽

Graft Versus Host ◽

Acute Graft

Download Full-text

N-acetyl-L-cysteine potentially inhibits complement activation in transplantation-associated thrombotic microangiopathy.

Transplantation and Cellular Therapy ◽

10.1016/j.jtct.2021.12.018 ◽

2021 ◽

Author(s):

Jiaqian Qi ◽

Hu Shuhong ◽

Xuefeng He ◽

Tingting Pan ◽

Liping Yang ◽

...

Keyword(s):

Complement Activation ◽

Thrombotic Microangiopathy

Download Full-text

Transplantation and Cellular Therapy
Latest Publications

TOTAL DOCUMENTS

H-INDEX

Published By Elsevier BV

Risk and predictive factors for candidemia after allogeneic hematopoietic cell transplantation: JSTCT Transplant Complications Working Group

PTCy-based Haploidentical vs Matched Unrelated Donor Peripheral Blood HSCT Using Myeloablative Targeted Busulfan-based Conditioning for Pediatric Acute Leukemia

Early recovery of myeloid-derived suppressor cells after allogeneic hematopoietic cells: comparison of post-transplantation cyclophosphamide to standard graft-versus-host disease prophylaxis

Human cytomegalovirus-specific T-cell reconstitution and late-onset cytomegalovirus infection in hematopoietic stem cell transplant recipients following letermovir prophylaxis

Real-world Experience of Cryopreserved Allogeneic Hematopoietic Grafts in the COVID-19 Pandemic: A Single Center Report

Outcomes Following Intolerance to Tacrolimus/Sirolimus Graft-Versus-Host Disease Prophylaxis for Allogeneic Hematopoietic Cell Transplantation

Incidence and risk factors of transplant-associated thrombotic microangiopathy (TA-TMA): a systematic review and meta-analysis

Mother donors improve outcomes after HLA haploidentical transplantation: A Study by the Cellular Therapy and Immunobiology Working Party of the EBMT

Mature naive B cells regulate the outcome of murine acute graft-versus-host disease in an IL-10 independent manner

N-acetyl-L-cysteine potentially inhibits complement activation in transplantation-associated thrombotic microangiopathy.

Export Citation Format

Transplantation and Cellular TherapyLatest Publications

TOTAL DOCUMENTS

H-INDEX

Published By Elsevier BV

Risk and predictive factors for candidemia after allogeneic hematopoietic cell transplantation: JSTCT Transplant Complications Working Group

PTCy-based Haploidentical vs Matched Unrelated Donor Peripheral Blood HSCT Using Myeloablative Targeted Busulfan-based Conditioning for Pediatric Acute Leukemia

Early recovery of myeloid-derived suppressor cells after allogeneic hematopoietic cells: comparison of post-transplantation cyclophosphamide to standard graft-versus-host disease prophylaxis

Human cytomegalovirus-specific T-cell reconstitution and late-onset cytomegalovirus infection in hematopoietic stem cell transplant recipients following letermovir prophylaxis

Real-world Experience of Cryopreserved Allogeneic Hematopoietic Grafts in the COVID-19 Pandemic: A Single Center Report

Outcomes Following Intolerance to Tacrolimus/Sirolimus Graft-Versus-Host Disease Prophylaxis for Allogeneic Hematopoietic Cell Transplantation

Incidence and risk factors of transplant-associated thrombotic microangiopathy (TA-TMA): a systematic review and meta-analysis

Mother donors improve outcomes after HLA haploidentical transplantation: A Study by the Cellular Therapy and Immunobiology Working Party of the EBMT

Mature naive B cells regulate the outcome of murine acute graft-versus-host disease in an IL-10 independent manner

N-acetyl-L-cysteine potentially inhibits complement activation in transplantation-associated thrombotic microangiopathy.

Transplantation and Cellular Therapy
Latest Publications